1 Article by Richard Zeifman
Psychedelics and Suicide-Related Outcomes: A Systematic Review.
Journal of clinical medicine – February 20, 2025
Summary
Suicide is a leading cause of death globally, emphasizing the urgent need for effective treatments. Recent findings suggest that psychedelics like psilocybin and MDMA may significantly reduce suicidal thoughts in individuals with mood and psychiatric disorders. Studies indicate notable improvements in suicidal ideation, showcasing the potential of these therapies for enhancing mental health outcomes.
Abstract
Background/Objectives: Suicide accounts for 1.4% of global deaths, and the slow-acting nature of traditional treatments for suicide risk underscore...